Extended warning on Didanosine-related pancreatitis.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects; D019469:Indinavir / Q000009:adverse effects; D019384:Nucleic Acid Synthesis Inhibitors / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D018119:Stavudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019384:Nucleic Acid Synthesis Inhibitors; D019469:Indinavir; D018119:Stavudine; D016049:Didanosine; D006918:Hydroxyurea